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Abstract: Surface plasmon resonance (SPR) biosensors utilize refractive index changes to 
sensitively detect mass changes at noble metal sensor surface interfaces. As such, they 
have been extensively applied to immunoassays of large molecules, where their high mass 
and use of sandwich immunoassay formats can result in excellent sensitivity. Small 
molecule immunosensing using SPR is more challenging. It requires antibodies or   
high-mass or noble metal labels to provide the required signal for ultrasensitive assays. 
Also, it can suffer from steric hindrance between the small antigen and large antibodies. 
However, new studies are increasingly meeting these and other challenges to offer highly 
sensitive small molecule immunosensor technologies through careful consideration of 
sensor interface design and signal enhancement. This review examines the application of 
SPR transduction technologies to small molecule immunoassays directed to different 
classes of small molecule antigens, including the steroid hormones, toxins, drugs and 
explosives residues. Also considered are the matrix effects resulting from measurement in 
chemically complex samples, the construction of stable sensor surfaces and the 
development of multiplexed assays capable of detecting several compounds at once. Assay 
design approaches are discussed and related to the sensitivities obtained. 
Keywords:  immunosensor; surface plasmon resonance (SPR); small molecule; steroid; 
toxin; conjugation 
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1. Introduction  
Surface plasmon resonance (SPR) is an opto-electronic phenomenon that occurs when a photon of 
light is incident upon a noble metal surface such as gold or silver [1]. When the wavelength of the 
photon equals the resonance wavelength of the metal, then the photon couples with the surface and 
induces the electrons in the metal surface to move as a single electrical entity called a plasmon. This 
oscillation of electrons sets up an electromagnetic field that exponentially decays out from the metal 
surface, with significant electrical field strength typically occurring within 300 nm of the surface. 
When molecules with sufficient mass bind to the surface within the range of the electric field, they 
perturb the plasmon and change the resonance wavelength. When dealing with a fixed planar surface, 
this is seen as a shift in the resonance angle of the incoming photons. These shifts essentially reflect 
minute refractive index changes on the surface and so can be used to very sensitively detect the binding 
of mass to the surface, typically down to a change of less than 1 × 10
−6 refractive index units (RIU) for 
more sophisticated instruments (Figure 1). Refractive index is a ratio that changes from 1.0003 in air  
to 1.33 in water. Resonance units (RU) are often used to quantify refractive index changes in SPR 
biosensors, with 1 RU = 1 × 10
−6 RIU, and so are used as units describing SPR signal strength. 
Figure 1. A schematic of the conventional Kretschmann optical configuration for SPR 
biosensing and the associated angle shift and sensorgram plot of resonance signal change 
with time [2]. Reprinted by permission from Macmillan Publishers Ltd: Nat. Rev. Drug 
Discov. 2002, 1, 515-528 copyright 2002; http://www.nature.com/nrd/index.html. 
 
 
Immunoassays involve the binding of an antibody to its target antigen, and so the antibody, being a 
high mass (approximately 150 kDa) protein, can act as the signal generator in SPR transduction. 
Immunoassays therefore naturally lend themselves to SPR biosensing, and this is particularly the case Sensors 2010, 10                                       
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for large molecule antigens (Mr > 2 kDa) which can be assayed in sandwich immunoassay formats. A 
sandwich immunoassay format would involve immobilizing antibodies onto the sensor surface, 
utilizing chemistries that include functionalized self-assembled monolayers (SAMs) [3], polymer 
coatings [4] and proteins such as protein A that orient antibodies on sensor surfaces [5]. The high mass 
antigen can then bind the immobilized antibody directly, thus generating biosensor signal and this 
signal can be further enhanced by binding a secondary antibody that recognizes another epitope on the 
antigen (Figure 2A). The design of large molecule immunoassays using SPR is now a very mature 
field of research. 
Small molecule antigens, however, pose challenges not encountered with large molecules. The 
foremost of these is that the antigen itself can not generate very much SPR signal, given its small mass. 
There are some reports of kinetics studies and assays using direct detection of small molecule targets 
but these generally suffer from low signal and poor sensitivity (Figure 2D). To obtain optimal assay 
sensitivity the antigen is therefore either labeled with a high mass label and used in competition with 
un-labeled sample antigen for binding to the surface in a competitive immunoassay, or the small 
molecule antigen is conjugated to the sensor surface and primary antibody is mixed with sample 
containing free antigen and the mixture is passed over the sensor surface (Figures 2B and C). In this 
case the mass is provided by the primary antibody and signal can be further enhanced by use of 
secondary antibodies either with or without conjugation to gold nanoparticles [4] (Figure 2B). In either 
case, the sensor signal is inversely proportional to the concentration of the antigen free in solution. 
Gold nanoparticles can provide signal enhancement both through their high mass and through 
cooperative plasmon enhancement by coupling between the localized plasmon field of the nanoparticle 
and the surface plasmon field of the gold sensor surface [6]. Small molecule assay formats require very 
careful design of the surface chemistry and the labeling employed so as to ensure optimal sensitivity. 
Another critical concern with small molecule immunoassay using SPR is the potential for steric 
hindrance of the binding between antigen and antibody when there is either a large label proximal to 
the antigen or where the antigen is bound to the sensor surface. Careful use of appropriate linker 
chemistry can help mitigate these constraints and improve binding signal and sensitivity. The stability 
of the immunobiosensor surface to the harsh solutions used to regenerate and re-use the surfaces ready 
for another assay must also be considered, particularly for high-throughput applications. The use of 
high quality antibodies with high affinity towards the target compound are also important to achieving 
high SPR sensor signal and low limits of detection (LOD). If the antibody binds the analyte strongly 
then smaller concentrations of the analyte may be needed to inhibit antibody binding to the sensor 
surface, thus reducing LOD. Typically, antibodies with affinity constants of 1–10 × 10
9 L/mol are 
desirable. Another major consideration is the resistance of the surface to biofouling caused by   
non-specific binding from high mass contaminants in complex real-world samples. These can both 
disrupt antigen/antibody binding and deposit high mass on the surface, potentially distorting 
immunoassay signals. 
This review will examine the general principles and parameters of small molecule immunoassays 
and how others have designed their immunosensor systems using SPR transduction. Specific classes of 
target small molecule antigens of particular interest are then investigated, namely steroids, toxins and 
food components, drugs and explosive residues, before some general comments are made on possible Sensors 2010, 10                                       
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future directions in small molecule SPR immunosensor research. A summary of some SPR 
immunoassays of small molecules is given in Table 1. 
Figure 2. A schematic of some typical SPR immunosensor formats. A. Sandwich 
immunoassay for large molecules. B. Protein conjugate immobilized indirect inhibition 
immunoassay (can also link via self-assembled monolayers (SAMs) or carboxymethyl 
dextran polymers) with optional secondary antibody-gold nanoparticle labeling in a second 
step. C. Protein-labeled inhibition immunoassay. D. Direct small molecule immunoassay.  
 
2. General Principles and Immunosensor Assay Formats  
When developing small molecule immunobiosensors for use with SPR transduction, one must first 
consider the structure and assembly of the sensing surface. The small molecule antigen can be 
immobilized to the gold surface via the commonly used carboxymethyl dextran polymer layers. These 
layers are functionalized with carboxylic acid groups that allow covalent attachment of antigen or 
antigen derivatives containing an amino group through the formation of an amide bond. Steroid 
hormones have been conjugated using this technique in a convenient in-situ flow-through 
immobilization technique within the biosensor by attaching a linker at a point on the antigen distant 
from existing functional groups [4]. The resulting functionalized surfaces can withstand up to more 
than 1,100 binding and regeneration cycles [4]. They use hydrophilic oligoethylene glycol (OEG) 
linkers which can project the antigen into the aqueous fluid stream and allow for optimal antibody 
binding [4,7]. Binding is also optimized through careful selection of the position of conjugation on the 
steroid so that linkers are attached distant from existing functional groups [7]. 
Another key consideration is the method of signal generation. With antigen-immobilized formats, 
the primary antibody can provide the signal but studies using steroid antigens have also employed 
secondary antibodies to further enhance the signal strength with enhancements of 6–8 times the 
primary antibody binding signal [4] (Figure 3). In addition to this enhancement approach, gold 
nanoparticles have been used to further enhance signal by adding more bound mass and through 
cooperative plasmon coupling. Gold nanoparticles concentrate a high mass into a small volume. Their 
A B
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surfaces allow convenient formation of coordinate bonds with thiol functional groups and so they can 
be easily conjugated to biomolecules as signal enhancement labels. The diameters of the nanoparticles 
can also be easily adjusted between 1–100 nm as required.  The noble metal nanoparticles also undergo 
SPR themselves and so when they approach a gold SPR sensing surface their plasmon modes can 
couple with those of the surface and produce a large shift in refractive index and thus an enhancement 
of SPR signal much larger than that expected on the basis of high mass labeling alone [6]. This 
labeling approach has been widely applied to SPR sandwich immunoassays of large molecules but has 
only recently been extended to small molecules. When 25 nm gold nanoparticles conjugated to 
secondary antibodies were employed, enhancements of 13-fold were achieved for immunosensing of 
progesterone with a LOD of 8.6 pg/mL [4]. Protocols for the enhancement of small molecule SPR 
immunosensing have now been standardized and these approaches can provide a generic platform for 
small molecule immunosensing combining linker chemistry with nanoparticle enhancement [8]. The 
range of small molecule analytes to which gold nanoparticle enhancement has been applied is now 
growing and includes the steroid hormone metabolite estriol-16-glucuronide [9,10], the antibiotic 
chloramphenicol [11] and the neurotoxin ochratoxin A [12]. Consideration has also been given to the 
effects on SPR signal enhancement of the diameter of the nanoparticles [13] and their distance from 
the sensing surface [14]. 
Figure 3. A sensorgram of the primary monoclonal antibody (mAb) binding response to a 
progesterone-immobilized SPR sensor surface and enhancement of binding signal with 
secondary antibody followed by regeneration. Reprinted from reference [4], with 
permission from Elsevier. Copyright 2005. 
 
 
Similar enhancement techniques can also be employed with other types of surfaces such as thiol 
SAMs terminating in carboxylic acid groups [3] (Figure 4). This approach has been used in 
combination with protein conjugates of the antigen to construct sensor surfaces for detection of 
progesterone [3], chloramphenicol [11] and ochratoxin [12]. In these cases gold nanoparticles of 10 
nm, 40 nm and 40 nm, respectively, were employed. Whilst SAMs allow the binding events to take 
place closer to the gold surface where the field strength is higher, they are typically less stable under 
regeneration than dextran surfaces [3]. Sensors 2010, 10                                       
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Figure 4. Standard curve plots for progesterone using a mixed SAM layer with protein-
conjugate immobilization for SPR immunosensing using mAb only (●), secondary 
antibody enhancement (○) and 10 nm immunogold enhancement (▼). Reprinted from 
reference [3], with permission from Elsevier. Copyright 2007.  
 
 
An alternative format for analyzing binding interactions in small molecule SPR immunosensing is 
to immobilize antibody and examine binding of small molecule protein conjugates. This approach has 
been used for progesterone when examining the effects of intermediate linker length on antibody 
binding strength, where a linker of 18-atoms was found to give high binding signal [15].  
Most SPR immunoassays for small molecules are conducted in a microfluidic environment. 
Mathematical models of the effect of various system parameters such as flow rate, antibody 
concentration, and density of binding sites on the surface have been developed to help optimize 
sensitivity [16]. Such modeling approaches have been applied to concentration gradient immunoassay 
where space and time-dependent binding is analyzed in a two-dimensional imaging SPR configuration 
with introduction of sample and antibody through ports in a T-shaped sensor [17]. This approach 
involves parallel streams of fluid, one containing analyte and the other antibody and analyzes the 
steady state gradient set up by interdiffusion between the fluid streams through binding to the 
immobilized antigen phenytoin [18]. 
Multiplexing assays in array formats is of increasing interest with small molecules, given the 
success of protein arrays [19]. SPR imaging is a format that utilizes the localized plasmon fields of 
specially patterned metal surfaces to detect SPR shifts spatially in two-dimensions. It is widely used in 
the study of protein binding interactions [20]. A photo-crosslinked small molecule platform has been 
successfully applied to detection of receptor binding to estrogens using SPR imaging [21]. Screening 
protein-protein interactions in a microarray format using scattered light under SPR conditions is 
emerging as an imaging SPR format [22] and may be adapted in future to small molecule immunoassays. 
Another key consideration is the continued functioning of the sensor in the presence of complex 
sample matrices such as serum [23] and human saliva. There is also on-going interest in making SPR 
small molecule sensor systems portable, and this is particularly useful in environmental measurements 
requiring on-site, real-time analysis. Benzo[a]pyrene and 2-hydroxybiphenyl have been detected using Sensors 2010, 10                                       
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an indirect competitive immunoassay where the SPR sensor system is confined to dimensions   
of 16 cm × 9 cm × 6 cm in a four flow-channel system [24]. 
Recently, interest has been building in alternatives to antibodies as binding agents in small molecule 
SPR formats. Aptamers (protein or oligonucleic acids that recognize specific target molecules) are 
being considered whereby binding between the aptamer and an immobilized partial complementary  
ss-DNA strand is disrupted by the presence of the small molecule target. This has been applied with 
gold nanoparticle labeling for detection of adenosine [25]. Such formats have shown detection 
performance down to 1 nM when used as an SPR biosensor for adenosine [26]. 
3. Steroids 
Analysis of steroid hormones is of interest to scientists investigating human physiology, 
optimization of athletic training regimes, monitoring of reproductive cycles in humans and animals for 
artificial insemination and pregnancy planning, and in the diagnosis and treatment of hormonal 
disorders. SPR has been applied to the measurement of progesterone in milk for potential use in 
monitoring estrous cycles in cows [27]. This system immobilizes progesterone ex-situ by removing the 
carboxymethyl dextran coated gold sensing surface from the chip cover and dispensing onto it a 
solution of 3-carboxymethyloxime derivative outside the SPR instrument. It demonstrated a LOD   
of 3 ng/mL which was later improved to 0.4 ng/mL in cow’s milk [27,28]. This system uses significant 
dilution to overcome matrix effects [27,28], which can compromise the overall assay sensitivity. 
Estradiol, in both serum and seawater has been sensed using a combination of SPR and a coupled 
online in-tube solid-phase microextraction (SPME) system. This inhibition immunoassay gave an LOD 
of 170 pg/mL [29]. Estradiol has been measured in buffer-based assays using OEG covalent linker 
conjugation and LOD of 25 pg/mL were obtained when conjugation position is carefully   
considered [7]. Another report utilizes an estradiol-protein conjugate for immobilization and achieves 
inhibition at concentrations of about 0.6–30 ng/mL [30]. In serum, SPR has shown that sex hormone 
binding globulin can form aggregates that may impact on protein immunoassay performance [31]. 
Testosterone and estradiol have been derivatized with biotin and pre-incubated with streptavidin before 
immobilization on the sensor surface. Subsequently, antibody binding kinetics were examined and 
showed good correlation with quartz crystal microbalance (QCM) results [32].  
The highly sensitive detection of the steroid hormones cortisol and testosterone in human saliva is 
of great interest to physiologists studying the effects of exercise on athletic performance. It can 
potentially provide a non-invasive means of monitoring hormonal fluctuations with time and could 
also be used to help diagnosis of hormonal disorders such as Addison’s disease and Cushing’s 
syndrome. Utilizing the covalent immobilization and OEG linker technology developed for 
progesterone [4], it has been possible to construct highly sensitive SPR immunoassays for both   
cortisol [33] and testosterone [34] (Figure 5). LOD of 49 pg/mL for cortisol and 15.4 pg/mL for 
testosterone have been reported in stripped human saliva matrix [33,34]. The typical physiological 
range is 0.1–10 ng/mL for salivary cortisol and 29–290 pg/mL for salivary testosterone [35]. The 
cortisol immunosensor uses secondary antibody enhancement of SPR signal [33], whilst the 
testosterone assay uses secondary antibody-nanogold enhancement to achieve greater sensitivity [34]. 
Non-specific binding has been reduced in the case of cortisol by the use of a surfactant in the antibody Sensors 2010, 10                                       
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diluents, which removes the need for chemical extraction or extensive pre-treatment of saliva   
samples [33]. Other groups have proposed the use of a combination of membrane filtration and an  
H-filter [36] to remove mucins and other high mass components in saliva or using a flow-filter 
arrangement [37] but this can add time, expense and complexity to the biosensor system [36] and risk 
repeated fouling of membranes. A cortisol-protein conjugate immobilized format has demonstrated an 
LOD of 1 ng/mL, insufficient to cover the full physiological range for salivary cortisol [37]. 
Subsequent work attempting direct immunoassay has demonstrated poor sensitivity, with reported 
linear detection regions >13 ng/mL for saliva and >9 ng/mL in urine [38]. Cortisol has also been used 
as a target antigen in the development of SPR immunosensors utilizing nanohole array substrates [39]. 
Such a set-up has the advantage of simple optics (they only need a simple UV-visible 
spectrophotometer) giving the potential for portable units to be constructed. Detection of small 
molecules such as the steroids in environmental samples is of increasing importance [40] as 
understanding is gained of their effects on freshwater and marine ecosystems, and so SPR has also 
been applied to environmental measurement of 17-estradiol in seawater [41]. 
Figure 5. Correlation plot for salivary cortisol samples analyzed by an SPR biosensor and 
by radioimmunoassay for 40 samples, from reference [33]. Reproduced by permission of 
The Royal Society of Chemistry (RSC). 
 
4. Toxins and Food Safety and Composition 
One of the key areas of interest in small molecule SPR immunosensing is the detection of toxins in 
foods and beverages to comply with increasingly strict requirements for food safety testing [42-44]. 
The key requirements are highly sensitive detection in complex matrices with high throughput. Also of 
interest is the detection of bioactives and additives in foods [42]. Much of the work in this area is 
focused on veterinary drugs, shellfish toxins and antibiotic residues, with less work devoted to 
mycotoxins. SPR is increasingly being explored as a transduction platform for such assays [45] along 
with other biosensor techniques, such as quartz crystal microbalance technology and electrochemical 
transduction [46]. Detection of toxins on-site using portable SPR is also beginning to be   Sensors 2010, 10                                       
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investigated [47]. The antibiotics neomycin and gentamycin have been measured in a parallel format 
using an imaging SPR system from IBIS Technologies, in a competitive assay with antibiotic 
immobilized through its amino groups to a carboxymethylated dextran. This resulted in detection 
ranges in the 1–50 ng/mL region [48]. The poor sensitivity is likely due to the absence of a linker 
between the antigens and the surface, or conjugation through an existing functional group. 
Mycotoxin immunoassay using biosensors has attracted attention as a new technology for food 
safety screening [49]. Combined detection of T-2 and HT-2 toxins is possible using SPR by organic 
extraction from baby food, breakfast cereal and wheat. LOD of 25–26 g/kg were obtained with CVs 
of 1.8–6.3% [45]. Fungal metabolites are often toxic, and an example is deoxynivalenol which can be 
conjugated to casein to coat an SPR biosensor surface for a competitive immunoassay [50]. These 
surfaces are reported to be stable for about 500 assay cycles but function in a high concentration range 
of 2.5–30 ng/mL [50]. Ochratoxin has been determined in cereals and wine using   
ochratoxin-OEG-ovalbumin protein conjugates on a SAM layer with 40 nm gold nanoparticle signal 
enhancement [12] (Figure 6). A radically different format for ochratoxin detection is based on hollow 
gold nano-sized balls coated in a dendritic thionine thin film for immobilization and sensing [51]. The 
technique was also tried in milk [51]. Staphylococcal enterotoxin can be detected in raw eggs using an 
antigen immobilized SPR competitive immunoassay which allows detection at 1–40 ng/mL from 
supernatant [52]. Aflatoxin B1 has been the subject of a protein conjugate-immobilized sensor format, 
with a polyclonal antibody and special regeneration conditions to overcome strong antibody   
binding [53]. In comparison, another study has favored using immobilized enzyme in an SPR format to 
detect aflatoxin [54].  
Shellfish toxin detection is another major application that has been explored extensively using SPR 
immunosensing. Okadaic acid has been detected by organic extraction from mussels and scallops and 
demonstrated minimal matrix effects in a direct competitive assay format and with an LOD   
of 0.24 ng/mL in mussel extract, allowing detection below European regulatory limits of 160 g/kg [55]. 
It has also been detected using an amine coupling method which has shown stability over more than 50 
assay cycles, though the immobilization method used may suffer from steric hindrance of antibody 
binding [56]. Antibodies have been raised to domoic acid and immunoassays established in both 
competitive and displacement assay formats, with the competitive format giving an LOD of 3 ng/mL 
and correlating well to HPLC when applied to measurement in clams [57]. Another study has shown 
that domoic acid-immobilized surfaces can be stable for 800 assay cycles, with measurement complete 
within 10 min and with reported LOD in the ng/g region, below the EU action limit of 20 g/g [58]. 
The binding interactions between domoic acid and polyclonal, monoclonal and recombinant antibodies 
have been examined using SPR formats with immobilized domoic acid [59]. A number of paralytic 
shellfish toxins have also been measured using SPR by employing a new saxitoxin polyclonal antibody 
and compared with ELISA and mass spectrometry techniques. The biosensor had a reported best LOD 
of 21.6 g/100 g of shellfish compared to a European regulatory limit of 80 g/100 g of shellfish [60]. 
Proteins of potential use in assays of saxitoxin have been screened using SPR by immobilizing the 
toxin via amine coupling onto the sensor surface [61]. 
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Figure 6. A: Plot of response (RU) v. primary antibody concentration for mAb only (●) 
and 40 nm immunogold enhancement (■). B: Assay standard curves for mAb only format 
(○) and 40 nm immunogold enhanced format (●). Reprinted from reference [12], with 
permission from Elsevier. Copyright 2009. 
 
 
SPR has also been used to probe the binding interactions between proteins and toxins and to 
examine such effects as the interaction between the ABC ring structure of ciguatoxin and its specific 
antibody, revealing that the bulkiness and aromatic nature of the antigen was critical to specific 
antibody recognition [62]. Another study has immobilized ciguatoxin using a 3-butene-1,2-diol side 
chain attached to the A-ring and then examined antibody binding interactions [63]. Tetrodotoxin has 
been measured using a modified OEG SAM surface structure, which achieved minimization of non-
specific binding and an LOD of 300 pg/mL [64] (Figure 7). Using this approach the ratios of the 
functionalized and blocking SAM thiol chains could be optimized to provide adequate spacing 
between immobilized antigen molecules to allow stronger antibody binding [64]. 2,4-D can be detected 
by using a protein conjugate [65,66] to immobilize the antigen and an indirect competitive assay 
format. The latest report indicates an LOD of 100 pg/mL using multiple flow channels [65]. An 
emerging related method is the use of total internal reflection ellipsometry, which may provide an Sensors 2010, 10                                       
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alternative transduction approach for sensitive detection of small molecule toxins such as T-2 
mycotoxin [67].  
Determination of food composition using SPR immunosensing appears to have attracted much less 
attention than toxins detection, but investigators have measured compounds such as vitamin B-5, 
which was measured in a wide range of foods including reference samples, giving a LOD of 4.4 ng/mL 
using buffer extraction [68]. 
Figure 7. Immobilization of tetrodotoxin onto a mixed thiol SAM on an SPR gold surface. 
Reprinted from reference [64], with permission from Elsevier. Copyright 2008.  
 
5. Drugs 
Localized surface plasmon resonance (LSPR) has been used for the detection of the drug stanozolol 
using immobilized gold nanoparticles [69,70]. Here stanozolol-protein conjugate is electrostatically 
adsorbed onto the gold, and antibody binding to the surface is detected with an LOD of 
0.7 ng/mL [70]. Often, detection of drug traces on surfaces is of interest, so a SensiQ
® SPR biosensor 
has been applied to detection of methamphetamine traces on ceramic tiles down to 25 ng/100 cm
2 [71]. 
Using LSPR, it is possible to multiplex assays in an array and this has been applied to simultaneous 
detection of cocaine, ecstasy, heroin and amphetamine using a combination of antibodies and with 
antigen-protein conjugates immobilized on the array and allowing both SPR and ellipsometric 
sensorgram readouts [72]. The beta-agonist clenbuterol has been detected in urine and serum and the 
matrix effects involved have been investigated [73]. This study found that non-specific binding from 
urine was greatly influenced by salt concentration and pH and that ultracentrifugation was effective in 
combating non-specific binding for both urine and serum [73]. Another format detects 
chloramphenicol using a SAM/protein conjugate surface and gold signal enhancement [11]. Fenicol 
antibiotic residues in shrimp have been examined using organic extraction followed by detection of 
four different fenicols over two flow cells using a direct amine coupling to carboxymethylated dextran 
without linkers [74]. Chloramphenicol can be detected in milk using a BIAcore
TM inhibition format 
involving amine coupling of the antigen to the sensor surface and using an antibody recognizing an 
epitope distant from the amine group and thus helping to improve antibody binding and Sensors 2010, 10                                       
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sensitivity [75]. An LOD of 0.1 ng/mL is reported [75]. Warfarin has been examined by SPR, with the 
formation of a panel of warfarin-protein conjugates which were then used to raise a selection of anti-
warfarin monoclonal antibodies [76]. These antibodies were then applied in inhibition assays of 
warfarin to determine the un-bound fraction in blood plasma ultrafiltrate [76]. This technique was 
compared with HPLC and gave a detection range of 4–250 ng/mL [76]. The sensor surfaces were 
produced by covalent amine coupling of 4’-aminowarfarin [76]. 
The study of binding interactions between antibodies and drug molecules is a rapidly emerging area 
where SPR’s biomolecular interaction analysis capability is being utilized to understand the kinetics of 
drug binding interactions. This field of fundamental biomedical research is too large to cover 
adequately in this review, but recent examples include the covalent immobilization of the drug 
panitumumab to a carboxymethylated BIAcore
TM surface by amine coupling to assess its clinical 
immunogenicity [77]. In another example, single-chain fragment variable (scFv) antibody fragments 
are identified that can recognize a heroin metabolite without recognizing morphine. The SPR biosensor 
was used to determine binding affinities using a biotin-PEG linker to conjugate the metabolite to the 
surface [78]. 
In addition to the detection of drugs in humans and animals, the determination of antibiotic residues 
in foods, and beverages such as milk, is also of significant interest as researchers look for alternatives 
to centralized LC-MS technology [79,68]. Immunosensors are seen as a potential way forward to faster 
and more affordable analysis [80]. -Lactams have been measured in milk using a SPR surface where 
the analyte is immobilized via an immunogenic interaction between H1 and its complement antibody 
and gives detection for penicillin G as low as 1–2 g/kg
 [81]. Benzimidazole carbamate residues have 
been detected in milk also, this time using a liquid extraction/partition technique and immobilized 
antigen-protein conjugate, giving an LOD of 2.7 g/kg [82]. Also detecting in milk, an imaging SPR 
system was developed to detect five different antibiotic residues in 10-fold diluted milk, with 
performance comparable to conventional SPR designs [83]. Taking multiplexing even further, 13 
fluoroquinolone antibiotics have been detected in poultry, fish and eggs [84,85] (Figure 8) giving 
detection for norfloxacin of below 0.5–1.5 ng/g [84]. Fluoroquinolone SPR has been compared with 
LC-MS techniques for identification of contaminated samples and has performed well in this regard 
and demonstrated time and sensitivity advantages over more conventional microbiological   
techniques [86]. Flumequine, another fluoroquinolone, has been measured in the blood serum and 
muscle of broiler chickens using immobilized antigen and detected concentrations of 15–
800 ng/mL [87].  SPR  techniques can also be used in concert with more conventional LC-MS 
techniques to analyze fluoroquinolones. The SPR biosensor can serve to screen the antibiotics of 
interest and identify relevant fractions for further investigation with LC-MS [88]. In the case of 
penicillin G detection in milk, enzymes have been applied in place of antibodies but still using SPR 
transduction [89]. 
The antibiotic cephalexin was detected in the range of 244–3,900 ng/mL in milk using an   
antigen-protein conjugate immobilized regenerable surface with a polyclonal antibody [90,91]. The 
high detectable concentration range in the assay could be attributed, at least in part, to the lack of a 
spacer chain between the cephalexin and the carrier protein and conjugation through an existing 
functional group on the drug analyte. Nicarbazin is a coccidiostat two-drug combination used as an 
additive to chicken feed to prevent disease outbreaks. One of these drugs, 4,4-dinitrocarbanilide is Sensors 2010, 10                                       
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detected in an SPR format that immobilizes a mimic of the drug on a carboxymethyl dextran surface 
for detection from liver and egg samples with LOD of 17–19 ng/g [92]. 
Figure 8. Assay standard curves for norfloxacin detection in chicken meat, egg and fish. 
Reprinted from reference [85], with permission from Elsevier. Copyright 2008.  
 
 
Some progress has been made in the development of prototype systems capable of high-throughput 
detection. Bile analysis for sulfamethazine and sulfadiazine has been reported, where up to eight 
samples can be simultaneously detected with a throughput of up to 650 samples per day with low false 
negative and false positive rates [93]. This prototype technology was also applied to measurement of 
clenbuterol and ethinylestradiol in urine and to sulfamethazine, sulfadiazine and enrofloxacin in   
milk [94]. An earlier report detailed a sulfamethazine immunoassay using SPR in animal urine with 
LOD of 5 ng/mL for use as a drug residue screening test [95]. This format interestingly uses   
anti-idiotypic antibodies immobilized on the sensor surface and detects sulfamethazine through the 
inhibition of monoclonal anti-sulfamethazine binding to the surface [95]. Sulfamethazine has also been 
detected in milk using covalent attachment of the antigen to a carboxymethyl dextran surface and 
trying two different antibodies, giving a best LOD of 1.7 g/kg [96]. An earlier study reported 
detection down to <1 nM in milk [97]. Use of a secondary antibody to further enhance the signal in 
sulfamethazine immunoassay using SPR allowed reduction of the primary antibody concentration 
used [97].   
BIAcore
TM SPR detection has been applied to ivermectin determination in bovine liver using 
acetonitrile extractions and solid phase extraction (SPE) clean-up with LOD of 19.1 ng/g [98]. 
Streptomycin residue detection has been examined in an indirect inhibition assay format using protein 
conjugate immobilization and in a direct assay format. Both of these approaches led to poor detection 
performance, with IC50 of 10–20 ng/mL [99]. 7-Hydroxycoumarin (umbelliferone) can be detected in 
human serum using SPR transduction where an antigen-protein conjugate is immobilized on a 
BIAcore
TM sensor chip measuring in the range of 0.5–80 g/mL [100]. The buffer composition was 
developed to try to minimize non-specific binding [100].  
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6. Explosives Residues 
 
SPR is beginning to be applied to detection of explosives residues [101], forming a growth area in 
SPR immunosensing. 2,4,6-Trinitrotoluene (TNT) has been detected using an indirect competitive 
format where a TNT analogue is immobilized to the sensor surface in the form of   
a 2,4,6-trinitrophenyl-keyhole limpet hemocyanin conjugate [102]. Various monoclonal and polyclonal 
antibodies were tested for their binding strengths, and a lowest LOD of 2 pg/mL was reported when 
using a polyclonal antibody raised to the same conjugate [102], showing that careful matching of the 
antibody and surface chemistry was central to obtaining good detection performance. TNT has also 
been assayed using a dendrimer-modified SPR surface [103]. In this format, a thiol SAM combined 
with a poly(amidoamine) (PAMAM) dendrimer provides the support structure for attachment of 
dinitrotoluene-keyhole limpet hemocyanin conjugate which serves as the immobilized antigen for 
competitive immunoassay of TNT using a monoclonal antibody and giving an LOD of 110 pg/mL on a 
regenerable surface [103]. Another study of TNT SPR immunosensing uses a mixed thiol SAM where 
some of the thiols act as blocking agents and others are functionalized for immobilization of the 
antigen [104]. Three TNT analogues are used for immobilization and their efficacy in the 
immunoassay is assessed. The surfaces are reported to exhibit low non-specific binding [104]. 
Irreversible gas-phase detection of TNT has also been reported using a dry surface [105].   
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) has been detected by an interesting SPR sensor 
construction that involves cross-linking gold nanoparticles using electropolymerized bisaniline   
cross-linking in the presence of Kemp’s acid, which yields an imprinted nanocomposite that 
demonstrated a high binding affinity for the explosive analyte [106]. The dielectric properties of the 
composite changes as -donor –acceptor complexes are formed, which alters the localized surface 
plasmons of the nanoparticles, giving a reported LOD of 12 fM [106]. An OEG functionalized surface 
has been used to detect 2,4-dinitrotoluene with SPR immunosensing, whereby the analyte is 
immobilized onto an OEG SAM and an indirect competitive immunoassay is set up using a specially 
prepared polyclonal antibody [107]. An LOD of 20 pg/mL was obtained and binding response 
maintained for more than 30 assay cycles [107]. 
Table 1. A summary of some SPR immunoassays of small molecules, giving the target 
analyte, the sample medium, reported limit of detection (LOD) and method of enhancement 
(if used). Note that researchers often use different methods for calculating LOD. 
Target   Medium  Reported LOD   Enhancement  Reference 
2,4,6-Trinitrotoluene Buffer  2  pg/mL  none  [102] 
2,4,6-Trinitrotoluene Buffer  110  pg/mL  none  [103] 
2,4,6-Trinitrotoluene Buffer  1,000  pg/mL  none  [104] 
2,4,6-Trinitrotoluene Vapour  700  pg/mL  none  [105] 
2,4-D  Buffer / river water  100 pg/mL  none  [65] 
2,4-D  Buffer / river water  8 pg/mL  antibody / protein  [65] 
2,4-Dinitrotoluene Buffer  20  pg/mL  none [107] 
2-Hydroxybiphenyl Buffer  100  pg/mL  none  [24] 
7-Hydroxycoumarin Serum    500,000  pg/mL  none  [100] Sensors 2010, 10                                       
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Table 1. Cont. 
Aflatoxin B1  Buffer  3,000 pg/mL  none  [53] 
Aflatoxin B1  Maize  970 pg/g  none  [54] 
Amphetamine Buffer  5,000  pg/mL none  [72] 
Benzimidazole carbamate  Milk extract   2,700 pg/g  none  [82] 
Benzo[a]pyrene Buffer  100  pg/mL  none  [24] 
Cephalexin  Buffer  4,880 pg/mL  none  [90, 91] 
Cephalexin  Milk  244,000 pg/mL  none  [90, 91] 
Chloramphenicol  Shrimp extract  100 pg/mL  none  [74] 
Chloramphenicol  Milk  100 pg/mL  secondary antibody  [75] 
Chloramphenicol  Buffer  0.00074 pg/mL  40 nm gold  [11] 
Cocaine Buffer  2500  pg/mL  none  [72] 
Cortisol  Saliva  49 pg/mL  secondary antibody  [33] 
Cortisol Buffer  360  pg/mL  none  [37] 
Cortisol Saliva  1,000  pg/mL  none  [37] 
Cortisol   Saliva / Urine  2,000 pg/mL  none  [38] 
Cortisone  Saliva / Urine  9,000 pg/mL  none  [38] 
Deoxynivalenol  Wheat extract  2,500 pg/ml  none  [50] 
Dihydrostreptamycin Milk 20,000  pg/mL  none  [99] 
Domoic acid  Clam extract  3,000 pg/mL  none  [57] 
Domoic acid  Shellfish   > 1000 pg/g  none  [58] 
Ecstasy Buffer  5,000  pg/mL  none  [72] 
Estradiol Serum/Seawater  170  pg/mL  none  [29] 
Estradiol  Buffer  25 pg/mL  secondary antibody  [7] 
Estradiol Buffer  600  pg/mL  none  [30] 
Estradiol Seawater  455  pg/mL none  [41] 
Estriol-16-glucruonide  Buffer  14 pg/mL  15 nm gold  [9] 
Estriol-16-glucruonide Urine  16  pg/mL  gold  [10] 
Florefenicol  Shrimp extract  200 pg/mL  none  [74] 
Florefenicol amine  Shrimp extract  250,000 pg/mL  none  [74] 
Flumequine  Chicken serum  15,000 pg/mL  none  [87] 
Flumequine Chicken  muscle  24,000  pg/g  none  [87] 
Heroin Buffer  500  pg/mL  none  [72] 
Ivermectin  Bovine liver   19,100 pg/g  none  [98] 
Methamphetamine Buffer 9,000  pg/mL  none  [71] 
Nicarbazin  Chicken Liver  17,000 pg/g  none  [92] 
Nicarbazin Egg  19,000  pg/g  none  [92] 
Norfloxacin  Poultry meat  500 pg/g  none  [84] 
Norfloxacin  Egg    1,000 pg/g  none  [84] 
Norfloxacin Fish  1,500  pg/g  none  [84] 
Norfloxacin  Fish /Poultry/Egg extracts  1,000-50,000 pg/g  none  [86] 
Ochratoxin A  Wine / beverages  58-400 pg/mL  40 nm gold  [12] 
Ochratoxin A  Buffer  10 pg/mL  none  [51] 
Okadaic Acid  Mussel extract  240 pg/mL  protein label  [55] 
Okadaic Acid  Shellfish   20,000 pg/g  none  [56] 
Penicillin G  Buffer / milk  1,000-2,000 pg/g  none  [81] Sensors 2010, 10                                       
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Penicillin G  Milk   2,600 pg/g  none  [89] 
Phenytoin Buffer  1,900  pg/mL  none  [18] 
Progesterone  Buffer  8.6 pg/mL  25 nm gold  [4] 
Progesterone  Buffer  4.9 pg/mL  10 nm gold  [3] 
Progesterone Milk  400-600  pg/mL  none  [27] 
Progesterone Buffer  35-60  pg/mL  none  [27] 
Progesterone Milk  3,000  pg/mL  none  [28] 
Progesterone  Buffer  100 pg/mL  protein label  [15] 
Saxitoxin  Shellfish    216,000 pg/g  none  [60] 
Stanozolol  Buffer  700 pg/mL  colloidal gold sensor surface  [70] 
Staphylococcal enterotoxin   Egg supernatant  1,000 pg/mL  none  [52] 
Streptamycin Milk  20,000  pg/mL  none  [99] 
Sulfadiazine  Porcine Bile  28,000 pg/mL  none  [93] 
Sulfamethazine  Porcine Bile  15,000 pg/mL  none  [93] 
Sulfamethazine  Animal urine  5,000 pg/mL  none  [95] 
Sulfamethazine Milk  1,700  pg/g  none  [96] 
Sulfamethazine  Milk  <278 pg/mL  secondary antibody  [97] 
T-2/HT-2 toxins  Cereals/baby food  25,000-26,000 pg/g  none  [45] 
Testosterone  Saliva  15.4 pg/mL  25 nm gold  [34] 
Tetrodotoxin Buffer  300  pg/mL none  [64] 
Thiamphenicol  Shrimp extract  500 pg/mL  none  [74] 
Vitamin B-5  Food extracts  4,400 pg/mL  none  [68] 
Warfarin  Plasma ultrafiltrate  4,000 pg/mL  none  [76] 
4. Conclusions  
The use of SPR transduction for the immunosensory detection of important small molecule analytes 
has expanded rapidly over recent years, with particular interest in developing routine testing methods 
for toxins in foods, and drug residues in both foods and biological fluids. Its use for sensitive detection 
of steroid hormones and explosive residues has now also been explored. From the research covered in 
this review, it is evident that, provided a good quality antibody is used, those studies that have most 
carefully examined the structure of the sensing surface have achieved the best results in terms of both 
sensitivity and surface stability. Some studies still use direct amine coupling to sensor surfaces without 
use of intermediate linkers and so may sacrifice sensitivity through steric obstruction of antibody 
binding. When factors such as linker lengths, conjugation techniques, protein and gold nanoparticle 
enhancement and regeneration stability are considered and optimized then highly sensitive small 
molecule immunosensor systems can be developed that can detect in the pg/mL concentration region 
and overcome the challenges of small analyte size and steric obstruction of binding interactions. In 
future, it seems likely that the range of small molecule analyte targets examined will expand and that 
even more attention will be devoted to sensor surface construction, both in terms of the chemical 
immobilization layers and the underlying metal substrate, particularly given the promise of LSPR 
techniques for multi-analyte detection. It is hoped that in time SPR immunosensing of small molecules Sensors 2010, 10                                       
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will become routine in testing laboratories and that portable SPR transduction units will expand the 
range of applications of plasmonics where on-site and near real-time detection is crucial. 
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